MedTrace Logo

Neuramis® Volume Lidocaine for Volume Augmentation in the Mid-Face

NCT03754413 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 236

Last updated 2021-03-19

No results posted yet for this study

Summary

To evaluate the effectiveness and safety of Neuramis® Volume Lidocaine for volume augmentation in the mid-face.

Conditions

  • Mid Face Volume Loss

Interventions

DEVICE

experimental

Neuramis® Deep Lidocaine

DRUG

comparator

No-treatment

Sponsors & Collaborators

  • Medy-Tox

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-05-29
Primary Completion
2020-03-09
Completion
2020-03-09

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03754413 on ClinicalTrials.gov